Verb Biotics
PrivateLast Round
Series A
Sep 9, 2021
Total Funding Raised
$30M
Company Overview
Verb Biotics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in September 2021.
Verb Biotics is a biotechnology company specializing in the development of innovative probiotic strains for nutrition, health, and wellness through advanced analysis and fermentation techniques.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Verb Biotics Comparables
Compare Verb Biotics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synbiotic Health | 87% | |
| Holobiome | 80% | |
| BIOHM Health | 78% |
For institutional investors. Book with your work email.
Verb Biotics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Verb Biotics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cascade Investment | Series A |
| Viking Global Investors | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2025
Added Ingredient AI, Inc. as a customer.
For institutional investors. Book with your work email.
Verb Biotics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Verb Biotics's valuation, stock price, and market status.
Is Verb Biotics a public or private company?
Verb Biotics is a private company.
What is the current stock price of Verb Biotics?
Verb Biotics is a private company, so its shares have no public market price. Caplight tracks Verb Biotics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Verb Biotics worth (valuation)?
Valuation information for Verb Biotics is not publicly available.
Can I buy Verb Biotics stock?
Verb Biotics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Verb Biotics's last funding round?
Verb Biotics's most recent funding round was Series A on September 9, 2021.
Who are the main investors in Verb Biotics?
Key investors in Verb Biotics include Cascade Investment, Viking Global Investors.
Will Verb Biotics IPO soon?
No public IPO plans have been announced for Verb Biotics.
How can I track Verb Biotics secondary market activity?
Caplight tracks bids, offers, and trades in Verb Biotics's shares on secondary markets.